M&T Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

M&T Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20	Closed	-$200	–	1692
2023 Q1	$200	Buy	+20	New	+$2.96K	﹤0.01%	1693
2022 Q2	–	Sell	-4	Closed	-$1K	–	1672
2022 Q1	$1K	Buy	+4	New	+$580	﹤0.01%	1544
2021 Q3	–	Sell	-4	Closed	-$4K	–	1591
2021 Q2	$4K	Hold	4	–	–	﹤0.01%	1578
2021 Q1	$5K	Hold	4	–	–	﹤0.01%	1530
2020 Q4	$7K	Hold	4	–	–	﹤0.01%	1652
2020 Q3	$3K	Buy	+4	New	+$496	﹤0.01%	1570
2020 Q1	–	Sell	-4	Closed	-$1K	–	1623
2019 Q4	$1K	Buy	+4	New	+$544	﹤0.01%	1408
2019 Q3	–	Sell	-4	Closed	-$1K	–	1634
2019 Q2	$1K	Hold	4	–	–	﹤0.01%	1597
2019 Q1	$2K	Buy	+4	New	+$522	﹤0.01%	1565
2018 Q4	–	Sell	-4	Closed	-$1K	–	1497
2018 Q3	$1K	Hold	4	–	–	﹤0.01%	1550
2018 Q2	$6K	Buy	+4	New	+$654	﹤0.01%	1519
2017 Q2	–	Sell	-4	Closed	-$7K	–	1651
2017 Q1	$7K	Buy	+4	New	+$521	﹤0.01%	1612
2016 Q4	–	Sell	-9	Closed	-$1K	–	1732
2016 Q3	$1K	Sell	9 -1	-10%	-$135	﹤0.01%	1700
2016 Q2	$4K	Sell	10 -990	-99%	-$146K	﹤0.01%	1643
2016 Q1	$4K	Hold	1,000	–	–	﹤0.01%	1678
2015 Q4	$3K	Hold	1,000	–	–	﹤0.01%	1710
2015 Q3	$1K	Hold	1,000	–	–	﹤0.01%	1793
2015 Q2	$11K	Sell	1,000 -2,600	-72%	-$467K	﹤0.01%	2019
2015 Q1	$178K	Hold	3,600	–	–	﹤0.01%	1770
2014 Q4	$161K	Buy	3,600 +500	+16%	+$83K	﹤0.01%	1818
2014 Q3	$157K	Buy	+3,100	New	+$477K	﹤0.01%	1953

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

M&T Bank's JAZZ Position: Q1 2026 in Review

M&T Bank reduced its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q1 2026, selling an estimated $40.2K and leaving 1,792 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1314.

M&T Bank first reported a position in JAZZ in Q1 2014 and has held it in 42 quarters since. The position peaked at $3.93M in Q1 2015. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

M&T Bank held 1,792 shares of Jazz Pharmaceuticals worth $339K as of Q1 2026.
M&T Bank sold 230 Jazz Pharmaceuticals shares in Q1 2026, an estimated $40.2K.
Jazz Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1314 holding.
M&T Bank first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 42 quarters since.
M&T Bank's Jazz Pharmaceuticals position peaked at $3.93M in Q1 2015.
571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.